Angela Pham, MD - Research

Research at a glance

Top areas of exploration

Crohn Disease , 3 publications
Micronutrients , 2 publications
Colitis, Ulcerative , 2 publications
Inflammatory Bowel Diseases , 2 publications

Research activity

13 publications

305 citations

Why is this important?

Active clinical trials

Palekona-GS-US-457-6411

The goal of this study is to learn if tilpisertib fosmecarbil (formerly known as GS-5290) is effective and safe in treating participants with moderate to severe ulcerative colitis. The study will compare participants in different treatment groups鈥�

Investigator: Angela Pham
Status: Accepting Candidates
Ages: 18 Years - 75 Years
Sexes: All

CorEvitas-IBD-600

This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for IBD in a cohort of patients cared for by gastroenterologists across North America. Secondary鈥�

Investigator: Angela Pham
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: All

My publications

13 publications

2024

Micronutrient deficiencies in inflammatory bowel disease: an incidence analysis.

European journal of gastroenterology & hepatology

鈥�

2024

Recurrence of Drug-Induced Lupus Secondary to Vedolizumab Use in a Patient With Crohn's Disease.

ACG case reports journal

鈥�

2023

Healthcare Utilization Patterns and Excessive Steroid Use in Late Adolescence Age and Young Adults With Crohn's Disease and Ulcerative Colitis.

Gastro hep advances

鈥�

2023

Perforation of the Transverse Colon After Migration of a Ventriculoperitoneal Shunt.

ACG case reports journal

鈥�

2023

Wernicke's Encephalopathy in Type 2 Achalasia: Case Report and Literature Review.

Journal of investigative medicine high impact case reports

鈥�

BOB体育